Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Tradegate
31.03.25
21:18 Uhr
6,450 Euro
-0,100
-1,53 %
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,5006,65021:33
6,5006,65021:33

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
SaLifecore Biomedical (LFCR) to Release Earnings on Thursday1
DoLifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 20251
17.03.Humanetics Selects Lifecore Biomedical to Deliver CDMO Services for BIO 3001
17.03.Lifecore Biomedical, Inc.: Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome1
17.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Special Stockholder Meeting2
17.01.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
07.01.Lifecore Biomedical to sell multi-purpose 10-head isolator filler1
07.01.Lifecore Biomedical Sells Excess Capital Equipment for $17M1
07.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million159Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
03.01.US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus6
02.01.Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS1
02.01.Lifecore Biomedical GAAP EPS of -$0.25 beats by $0.04, revenue of $32.56M beats by $2.81M2
02.01.Lifecore Biomedical Earnings Report: Q2 Overview2
02.01.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
02.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update136-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately $24.3...
► Artikel lesen
02.01.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
19.12.24Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 20251
19.12.24Lifecore Biomedical to Provide CDMO Services to Nirsum Labs1
19.12.24Lifecore unterstützt Nirsums Phase-2-Studie für Opioid-Behandlung1
19.12.24Lifecore to support Nirsum's phase 2 opioid treatment trial1
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1